Cargando…
The Osteoblastogenesis Potential of Adipose Mesenchymal Stem Cells in Myeloma Patients Who Had Received Intensive Therapy
Multiple myeloma (MM) is characterized by advanced osteolytic lesions resulting from the activation of osteoclasts (OCs) and inhibition of osteoblasts (OBs). OBs are derived from mesenchymal stem cells (MSCs) from the bone marrow (BM), however the pool and function of BMMSCs in MM patients (MM-BMMSC...
Autores principales: | Lin, Hsiu-Hsia, Hwang, Shiaw-Min, Wu, Shang-Ju, Hsu, Lee-Feng, Liao, Yi-Hua, Sheen, Yi-Shuan, Chuang, Wen-Hui, Huang, Shang-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983165/ https://www.ncbi.nlm.nih.gov/pubmed/24722177 http://dx.doi.org/10.1371/journal.pone.0094395 |
Ejemplares similares
-
Osteoblastogenesis of adipose-derived mesenchymal stem cells in chronic kidney disease patient with regular hemodialysis
por: Tjempakasari, Artaria, et al.
Publicado: (2022) -
Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis
por: Shyu, Jia-Fwu, et al.
Publicado: (2021) -
Activated B Lymphocyte Inhibited the Osteoblastogenesis of Bone Mesenchymal Stem Cells by Notch Signaling
por: Pan, Mengxue, et al.
Publicado: (2019) -
LIGHT/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease
por: Brunetti, Giacomina, et al.
Publicado: (2014) -
Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post‐hoc analysis of the EXTEND study
por: Meyer, Oliver, et al.
Publicado: (2021)